Last Updated on
February 13, 2025
By
ExcedrProducing a drug substance or product isn't just about expertise in formulation; it requires specialized staff, equipment, and manufacturing facilities. Unfortunately, many life science companies lack the in-house resources, experience, or capital to scale production efficiently. Even if a company has the means to invest in building manufacturing capabilities, doing so can be a massive financial risk—especially for drugs or devices that may fail in clinical trials.
So, what are your options when you have a promising treatment ready for commercialization but lack the infrastructure to manufacture it at scale?
From large pharmaceutical firms to biopharma startups, many organizations turn to Contract Manufacturing Organizations (CMOs) or Contract Development and Manufacturing Organizations (CDMOs) to bridge this gap. These specialized partners help companies produce drug formulations efficiently without the burden of investing in costly manufacturing facilities.
By outsourcing drug development and manufacturing, businesses can accelerate time to market, optimize resources, and focus on core areas such as drug discovery and commercialization. Depending on the CMO you choose, you can leverage their expertise and infrastructure to ensure high-quality, compliant manufacturing throughout the development process.
In this guide, we’ll explore the role of CMOs and CDMOs, their services and facilities, cost considerations, and key factors to help you decide when, why, and where to outsource your manufacturing needs.
Contract Manufacturing Organizations (CMOs) provide drug manufacturing services to life science companies on a contract basis. They are particularly valuable to companies that lack the resources, expertise, or infrastructure to produce their products in-house. By outsourcing to a CMO, businesses can scale production efficiently while saving on the costs of building manufacturing facilities and hiring production teams.
CMOs specialize in manufacturing drug products and often have the specialized equipment and expertise needed for mass production. This allows them to produce pharmaceuticals more efficiently and cost-effectively than companies managing manufacturing internally.
Some CMOs also offer drug development services, in which case they are referred to as Contract Development and Manufacturing Organizations (CDMOs). While CMOs typically focus on manufacturing pre-formulated drugs, CDMOs handle everything from drug discovery and formulation development to clinical trials before manufacturing. However, the distinction isn’t always strict—many CMOs provide services similar to CDMOs. The key is understanding your specific needs and ensuring the organization you choose offers the right services.
For example, if you have a pre-formulated drug, you may only need a CMO to handle production. However, if you require help with development, working with a CDMO that supports pre-manufacturing processes would be a better fit.
Your company’s business model and industry focus can also influence your choice of CMO or CDMO. These organizations commonly work with biotech, biopharma, and pharmaceutical companies, but some specialize in specific industries or product types. Whether you’re a startup, a small to mid-sized business, or a large enterprise, there are CMOs suited to meet your needs.
CMOs and CDMOs support a wide range of product development and manufacturing needs, including drugs, therapeutics, medical devices, and biologics. Choosing the right partner ensures that your product is developed and manufactured efficiently, with the necessary expertise to navigate complex regulatory and production challenges.
There are many different types of contract manufacturing organizations. This can include general CMOs or more specialized organizations—organizations that specialize in pharmaceuticals, medical devices, or consumer products. The specific type of CMO you should partner with will depend on the specific needs of your product and your manufacturing requirements.
The three primary ways you can categorize contract manufacturing are: contract structure, supported industries, and services, tools, and materials:
You can choose between different types of contract manufacturing agreements. They include private label manufacturing, labor/service subcontracting, individual component or part manufacturing contracts, and end-to-end service contracts.
Some contract manufacturers specialize in certain industries. It’s important to choose a manufacturer that understands the needs of your customers as well as your industry’s market and regulations.
In addition to the types of contract agreements offered and industries supported, CMOs will also have different manufacturing processes and types of tools or materials they use. This will not only determine whether or not the organization can help you, it will also have an impact on the quality of the products and how quickly the products can go to market.
CMOs and CDMOs offer a range of manufacturing and development services tailored to different types of drugs and medical products. Some organizations focus solely on commercial manufacturing, while others provide both development and production support.
Contract manufacturers and developers may offer:
For companies requiring support earlier in the process, services can include:
Your partnership with a CMO/CDMO depends on your product’s stage in development:
For example, a biopharma company working with a CMO typically provides its formula or product design. The contract manufacturer then oversees production, creating a prototype for testing. After refining the product based on results, full-scale manufacturing begins, ensuring timely delivery within the agreed-upon terms.
CMOs also offer specialized services to support development and compliance, including:
Some CMOs even conduct clinical trials, assisting with site selection and study monitoring to ensure adherence to protocols and good clinical practices. This includes data management, patient safety oversight, and regulatory compliance. By leveraging these services, pharmaceutical and biotech companies can streamline development, reduce costs, and accelerate time-to-market while ensuring quality and regulatory adherence.
The cost of working with a Contract Manufacturing Organization (CMO) varies widely depending on several key factors. Understanding these cost drivers can help you budget effectively and choose the right CMO for your needs.
CMOs use various pricing models depending on the type of service provided:
Because costs can vary significantly, CMOs typically provide detailed customized quotes based on your specific project requirements. When seeking quotes:
While cost is a key factor, the cheapest option isn’t always the best. High-quality production, regulatory compliance, and reliability are just as important as cost savings. A well-chosen CMO can provide long-term value by ensuring efficient production, minimizing delays, and helping navigate regulatory hurdles. By understanding these cost factors and pricing structures, you can make a more informed decision and ensure a successful partnership with the right CMO.
Like many services and solutions in the life sciences industry, there are both advantages and drawbacks to using a contract manufacturing organization. Let’s review:
Hiring a CMO offers several advantages that can play a vital role and make a huge difference in both small and large businesses’ operations.
In other words, when you work with the right contract manufacturer, you can experience cost savings, increased capacity, production flexibility, access to specialized equipment, and more.
Hiring a CMO also presents a number of potential drawbacks. These can include:
It’s important to carefully consider the pros and cons of working with a CMO. While doing so can be cost-saving, it can also lead to higher costs depending on the organization. The same goes for quality. You will likely end up with a high-quality drug product, but it is still entirely possible to end up with something that is low quality and does not meet ISO standards.
Outsourcing to a CMO or CDMO can be beneficial in a number of situations, including:
Outsourcing should be carefully evaluated based on cost, drug complexity, and in-house capabilities. If your company lacks the necessary equipment or expertise, a CMO can be a cost-effective alternative to building in-house capacity. Comparing the costs and benefits of outsourcing versus internal production is key to making the right decision.
The type of CMO you should consider partnering with will depend on a number of factors, including the specific drug you are developing, the stage of development, and your budget. It is important to carefully evaluate the qualifications and track record of any CMO you are considering partnering with, and to compare their services and fees with those of other CMOs.
When selecting a CMO, consider some of the following factors:
Carefully evaluate the qualifications and experience of the CMO you are considering partnering with. Ensure that they have the necessary expertise and resources to support your drug development project.
The difference between a Contract Manufacturing Organization (CMO) and a Contract Development and Manufacturing Organization (CDMO) comes down to scope. CMOs focus on manufacturing pre-formulated drugs, handling production, packaging, and scalability. CDMOs, on the other hand, offer a more comprehensive range of services, including drug development, regulatory support, quality control, and supply chain management. If your product is already developed and you just need a manufacturing partner, a CMO is the right fit. But if you need help with early-stage development in addition to manufacturing, a CDMO provides a more complete solution.
Then there’s the Contract Research Organization (CRO), which plays a different role. While CMOs and CDMOs focus on production, CROs specialize in research and clinical trials—helping with study design, data management, and statistical analysis. Some CMOs offer limited drug discovery and development services, creating overlap with CROs, but the key distinction is that CROs do not handle manufacturing. Companies typically work with a CRO during drug development, then transition to a CMO or CDMO when it's time to produce the drug.
So how do you decide? If you're in the research phase and need help with clinical trials, a CRO is the right choice. If you’re ready to manufacture, a CMO will get the job done. And if you need both development and manufacturing, a CDMO is the best fit. Choosing the right partner depends on where you are in the process and what expertise you need to bring your product to market efficiently.
Bringing a new drug to market is a complex, resource-intensive process, requiring careful navigation through regulatory hurdles, manufacturing challenges, and financial constraints. While some companies choose to build out in-house capabilities, working with a CMO or CDMO can often be a more efficient and cost-effective way to scale production, mitigate risk, and accelerate time to market. The right manufacturing partner provides valuable expertise at every stage, helping ensure a high-quality, compliant final product.
Before reaching the manufacturing stage, in-house research and development is critical. Cutting-edge lab equipment plays a key role in early-stage drug discovery and formulation, but the high upfront costs can be a major challenge. Rather than making large capital investments, many biotech, biopharma, and pharmaceutical companies explore leasing as a flexible alternative.
If you're looking for a way to equip your lab with high-quality instruments without the burden of large upfront costs, Excedr’s leasing program offers a cost-effective solution. Whether you need new or refurbished equipment to optimize research, improve results, or accelerate R&D, leasing can help bridge the gap between early-stage development and full-scale manufacturing. When the time comes to transition from R&D to production, you’ll be well-positioned to partner with a CMO or CDMO to bring your product to market.